Geographically, global infertility diagnosis and treatment market is divided into North America, Europe, Asia Pacific and Rest of the world. North America is the largest market for the infertility diagnosis and treatment owing to changing lifestyle, increasing geriatric population, rising awareness regarding infertility diagnosis and treatment are some of the few factors that pushes this region upward. However, APAC is growing at a massive pace owing to increasing medical tourism, and so on. China and India are the major countries in this region.
Key companies profiled in the report are Bayer AG, Bristol-Myers Squibb CO., Church & Dwight Company INC., Cook Medical, INC., Coopersurgical INC., Eli Lilly & CO., Emd Serono, INC., Endo Pharmaceuticals INC., Ferring Pharmaceuticals, Genea, Glaxosmithkline PLC, Halotech DNA, Irvine Scientific, Janssen Pharmaceutical, Novartis International AG, Origio, Ovascience, Pfizer Inc., Princeton Biomeditech CORP., Progyny, Quidel CORP., Vitrolife AB, Vivus INC. These companies use many strategies such as merger and acquisition, product launch, geographical expansion and so on to dominate their global presence.
The market study of infertility diagnosis and treatment market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
Financial reports of companies involved in the market
Authentic Public Databases
Whitepapers, research-papers and news blogs
Company websites and their product catalogue.
Supplier Websites such as Alibaba, amazon for pricing analysis.
The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.
Global infertility diagnosis and treatment market is segmented on the basis of infertility diagnosis, infertility treatment and regional outlook.
Global Infertility diagnosis and treatment Market Research and Analysis, By infertility diagnosis
Global Infertility diagnosis and treatment Market Research and Analysis, By infertility treatment
Global infertility diagnosis and treatment Market Research and Analysis, By Region
The Report Covers:
Comprehensive research methodology of Global infertility diagnosis and treatment market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global infertility diagnosis and treatment market.
Insights about market determinants which are stimulating the Global infertility diagnosis and treatment market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.2. Analyst & Current Market Trends
2.2.1. Key Findings
2.3.1. Tax Laws
220.127.116.11. United States
18.104.22.168. European Union
22.214.171.124. Rest of the World
3. Market Determinant
3.1.1. Lifestyle Factor Such As Smoking, Stress and Weight Augment the Infertility
3.1.2. Female Age Factor (Age Above 35 Years)
3.1.3. Increased Success Rate of Ivf Treatment Is Driving the Market
3.1.4. High Prevalence Rate of Infertility In Male and Female Both
3.1.5. Increase In New Technologies To Avoid Multiple Embryo Implants
3.2.1. Cost Structure Is a Restraint For the Market
3.2.2. Lack of Infrastructure In Developing Countries
3.2.3. Reimbursement Policies In Various Geographies Are Restraining the Market
3.3.1. Emerging Market Such As India and China Are Most Opportunity Markets
3.3.2. Medical Tourism In Developing Countries
4. Market Segmentation
4.1. Global Infertility Diagnosis and Treatment Market, By Diagnosis
4.1.1. Male Infertility Diagnosis
126.96.36.199. Semen Analysis
188.8.131.52. Genetic Testing
184.108.40.206. Testicular Biopsy
220.127.116.11. Hormone Testing
18.104.22.168. Other Testing
4.1.2. Female Infertility Diagnosis
22.214.171.124. Ovulation Testing
126.96.36.199. Imaging Testing
188.8.131.52. Ovarian Reserve Testing
184.108.40.206. Hormonal Level Testing
220.127.116.11. Genetic Testing
18.104.22.168. Others Testing
4.2. Global Infertility Diagnosis and Treatment Market, By Infertility Treatment
4.2.1. Male Infertility Treatment
22.214.171.124. Drugs and Medicine
126.96.36.199. Assisted Reproductive Technology (Art)
4.2.2. Female Infertility Treatment
188.8.131.52. Drugs and Medicine
184.108.40.206. Intrauterine Insemination (Iui)
220.127.116.11. Assisted Reproductive Technology (Art)
18.104.22.168.1. In Vitro Fertilization
22.214.171.124.2. Intracytoplasmic Sperm Injection (Icsi)
126.96.36.199.3. Assisted Hatching
5. Competitive Landscape
5.1. Market Share Analysis
5.2. Key Company Analysis
6. Regional Analysis
6.1. North America
6.1.1. United States
6.2.1. United Kingdom
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.4. Rest of Asia Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Bayer Ag
7.2. Bristol-Myers Squibb Co.
7.3. Church & Dwight Company Inc.
7.4. Cook Medical, Inc.
7.5. Coopersurgical Inc.
7.6. Eli Lilly & Co.
7.7. Emd Serono, Inc
7.8. Endo Pharmaceuticals Inc.
7.9. Ferring Pharmaceuticals
7.11. Glaxosmithkline Plc
7.12. Halotech Dna
7.13. Irvine Scientific
7.14. Janssen Pharmaceutical
7.15. Novartis International Ag
7.18. Pfizer Inc.
7.19. Princeton Biomeditech Corp.
7.21. Quidel Corp
7.22. Vitrolife Ab
7.23. Vivus Inc.
- Bayer Ag
- Bristol-Myers Squibb Co.
- Church & Dwight Company Inc.
- Cook Medical, Inc.
- Coopersurgical Inc.
- Eli Lilly & Co.
- Emd Serono, Inc
- Endo Pharmaceuticals Inc.
- Ferring Pharmaceuticals
- Glaxosmithkline Plc
- Halotech Dna
- Irvine Scientific
- Janssen Pharmaceutical
- Novartis International Ag
- Pfizer Inc.
- Princeton Biomeditech Corp.
- Quidel Corp
- Vitrolife Ab
- Vivus Inc.